Projects per year
Personal profile
Biography
I am a Senior Research Fellow with the Centre for Medicine Use and Safety. I am currently funded by an NHMRC Investigator Grant (EL2: 2021-2025). I am also a qualified pharmacist with experience working as a clinical pharmacist in a large tertiary teaching hospital. I completed my PhD at the University of South Australia in 2014 and was awarded the medal from the School of Pharmacy and Medical Sciences for my thesis work. Following this I was a postdoctoral research associate at the University of Sydney with the NHMRC Cognitive Decline Partnership Centre. I also spent two months as a visiting researcher at the Brocher Foundation (Geneva, Switzerland) in 2014. I previously held an NHMRC-ARC Dementia Research Development Fellowship. The first two years of this fellowship were undertaken in Canada with the University of Sydney and the Department of Medicine at Dalhousie University, with the final two years completed at University of South Australia. I hold affiliate status with the College of Pharmacy, Dalhousie University.
Research area keywords
- Deprescribing
- Polypharmacy
- Geriatrics
- Pharmacy Practice
- Health Services Research
- Consumer involvement
- Dementia
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Principles for optimising medicines management in older people living with frailty and dementia
Liau, S. (Primary Chief Investigator (PCI)), Reeve, E. (Chief Investigator (CI)), Thompson, J. (Chief Investigator (CI)) & Sawan, M. J. (Chief Investigator (CI))
1/02/25 → 31/10/26
Project: Research
-
Educating health professionals through a Knowledge Transfer Framework to reduce use of high-risk, and/or unnecessary medicines
Reeve, E. (Primary Chief Investigator (PCI)), Turner, J. (Chief Investigator (CI)), Cross, A. (Chief Investigator (CI)), Bell, S. (Chief Investigator (CI)), Liau, S. (Chief Investigator (CI)), Langford, A. (Chief Investigator (CI)), Galbraith, K. (Chief Investigator (CI)), Palermo, C. (Chief Investigator (CI)), Ottrey, E. (Chief Investigator (CI)), Haines, T. (Chief Investigator (CI)), Manias, E. (Chief Investigator (CI)), Nielsen, S. (Chief Investigator (CI)), Buchbinder, R. (Chief Investigator (CI)), O'Connor, D. (Chief Investigator (CI)), Wale, J. (Chief Investigator (CI)), Shakib, S. (Chief Investigator (CI)), Magin, P. J. (Chief Investigator (CI)), Laver, K. E. (Chief Investigator (CI)), Hilmer, S. N. (Chief Investigator (CI)), Etherton-Beer, C. (Chief Investigator (CI)) & Malone, D. (Chief Investigator (CI))
31/01/25 → 31/01/28
Project: Research
-
Integration and implementation of deprescribing recommendations to reduce medication induced harm
Reeve, E. (Primary Chief Investigator (PCI)) & Owens, N. (Project Manager)
4/04/22 → 31/12/26
Project: Research
-
Integrating international preferences on deprescribing recommendations into the update of the Antihyperglycaemics Deprescribing Guideline
Liau, S. (Primary Chief Investigator (PCI)), Reeve, E. (Chief Investigator (CI)) & Thompson, W. (Chief Investigator (CI))
1/01/25 → 31/12/25
Project: Research
-
The RM Gibson Program
Langford, A. (Primary Chief Investigator (PCI)), Reeve, E. (Chief Investigator (CI)) & Wale, J. (Chief Investigator (CI))
1/08/23 → 31/01/25
Project: Research
-
Deprescribing in Clinical Practice: Evidence, Implementation, and the Role of Pharmacists
Liau, S. J., Falconer, N., Liu, B. M., Scott, I. A., Hilmer, S. N. & Reeve, E., 2026, Reference Module in Biomedical Sciences. Elsevier, p. 1-22 22 p. (Elsevier Reference Collection in Biomedical Sciences).Research output: Chapter in Book/Report/Conference proceeding › Encyclopaedia / Dictionary Entry › Other › peer-review
-
Incentivizing Deprescribing for Health Care Quality Not Quantity
Langford, A. V., Reeve, E., Lin, C. W. C. & Qaseem, A., May 2026, In: Annals of Internal Medicine. 179, 5, p. 742-743 2 p.Research output: Contribution to journal › Comment / Debate › Other › peer-review
Open Access -
Integrating patient education on deprescribing into care delivery: Learnings from the Optimize pragmatic trial
Bayliss, E. A., Gleason, K. S., Sheehan, O. C., Drace, M. L., Kraus, C., Bedoy, R., Martinez, A. E., Sawyer, J. K., Norton, J., Weffald, L. A., Green, A. R., Reeve, E., Pieper, L. E., Maiyani, M. & Boyd, C. M., Jan 2026, In: Patient Education and Counseling. 142, 5 p., 109392.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Patients’ attitudes towards deprescribing disease modifying anti-rheumatic drugs in rheumatoid arthritis
Fraser, L., Wiese, M. D., Ailabouni, N., Ellett, L. K., Sirois, C., Berthelot, W., Proudman, S. M., McWilliams, L. & Reeve, E., Feb 2026, In: Patient Education and Counseling. 143, 6 p., 109432.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
A scoping review of disease-modifying antirheumatic drug nonadherence in rheumatoid arthritis: Measurement, prevalence and implications for clinical practice
Fraser, L., Ailabouni, N., Ellett, L. K., Tan, J. M., Freeman, A., Proudman, S. M., Reeve, E. & Wiese, M. D., Dec 2025, In: British Journal of Clinical Pharmacology. 91, 12, p. 3330-3340 11 p.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access1 Link opens in a new tab Citation (Scopus)